The term hybrid imaging essentially refers to hardware-based image fusion where two different imaging modalities are combined in a single equipment. As image fusion through the hardware approach offers several advantages over software-based image fusion, such as accuracy of image co-registration and ease of image fusion through a single scan session, to name a few, hybrid scanners such as positron emission tomography-computed tomography (PET-CT) were introduced in 2001, followed by the introduction of single photon emission computed tomography-computed tomography (SPECT-CT) hybrids in 2003. These two modalities are established in the market today, with PET-CT being the standard of care in oncology and SPECT-CT an upcoming hybrid modality currently being used mainly for cardiac scans. Presently, attempts are also being made to bring out hybrid imaging platforms, such as MRI-Optical imaging CT-optical imaging, and so on. These modalities are expected to have significant penetration potential mainly in clinical segments, such as oncology, cardiology, and neurology.
To realize the full potential of hybrid imaging, clinical and technical expertise from diverse fields must be brought together. Molecular imaging has become an important tool for preclinical and clinical research and diagnosis, especially across clinical areas such as oncology, cardiology, neurology, pharmacology, and so on. Molecular imaging also shows much potential in accelerating the transfer of laboratory research into clinical practice. Of all the hybrid modalities available for molecular, functional and structural imaging, PET is at present the most powerful and versatile and PET/CT is growing more rapidly than any other hybrid imaging technique. Not only is the combination sensitive and quantitative, but the broad range of available positron-emitting radionuclides makes it ideal for research and discovery of human illness and for drug development. Although hybrid PET/CT already has a number of important clinical applications, the application area is expected to diversify further in the coming years.
This research service—Impact of Hybrid Imaging Platforms—by TechVision is a study on the technology trends in the area of hybrid imaging. For the scope of the study, hybrid imaging has been split into six categories, namely, PET/CT, SPECT/CT, MR/PET, MR/SPECT, USG/MR and MRI/CT. This research service discusses the research and development (R&D), technology and application trends in the field of hybrid imaging. At times, the terms “multimodality imaging” or “fusion imaging” have been used synonymously with “hybrid imaging”. This research service also covers the following key sections:
Technology Capability and Value Chain
Market Impact Assessment
Electronic Access - Site License Fulfilled By Publisher
Electronic Access - Global site License Fulfilled By Publisher